Neratinib, a multi-targeted receptor tyrosine kinase inhibitor in advanced Non-small-cell Lung Cancer with exon 18 mutations EGFR mutations

Nerlynx (neratinib) - Puma

Wenfeng Fang; Ning Li; Runxiang Yang; Ying Cheng; Baogang Liu; Haiyong Wang; Lin Wu; Qiming Wang

Jul 17, 2026